Eurobio Scientific SA
PAR:ALERS

Watchlist Manager
Eurobio Scientific SA Logo
Eurobio Scientific SA
PAR:ALERS
Watchlist
Price: 25.35 EUR
Market Cap: 253.6m EUR

During the last 3 months Eurobio Scientific SA insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 0% over this period (open performance analysis).

The last transaction was made on Dec 18, 2023 by Denis Fortier (General Manager) , who bought 7.6k EUR worth of ALERS shares.

Last Transactions:
Denis Fortier
General Manager
€+7.6k
Denis Fortier
General Manager
€+15.2k
Denis Fortier
General Manager
€+7.6k
Denis Fortier
General Manager
€+1.6k
Denis Fortier
General Manager
€+2.9k
Denis Fortier
General Manager
€+16.6k
Denis Fortier
General Manager
€+8.3k
Denis Fortier
General Manager
€+16.6
Denis Fortier
General Manager
€+16.5k
Denis Fortier
General Manager
€+8.3k
Denis Fortier
General Manager
€+8.3k
Eurobionext
President
€+495.7k
Eurobionext
President
€+5m
Denis Fortier
General Manager
€+23.9m
Denis Fortier
General Manager
€-10.6m
Denis Fortier
General Manager
€-500.3k
Jean-Michel Carle Grandmougin
Chief Scientific Officer
€-15.6m
Catherine Duchesne De Lamotte Personne Liée À Hervé Duchesne
€-101.1k
Hervé Duchesne De Lamotte
Chief Financial Officer
€-292.2k
Margaux Fortier Personne Liée À Denis Fortier
€-883.8k
Margaux Fortier Personne Liée À Denis Fortier
€-416.1k
Lucie Fortier Personne Liée À Denis Fortier
€-883.8k
Lucie Fortier Personne Liée À Denis Fortier
€-416.1k
Cécile Fortier Personne Liée À Denis Fortier
€-500k
Eurobionext Société Par Actions Simplifiés
Président
€+46.1m
Eurobionext Société Par Actions Simplifiés
Président
€+35m
Jean-Michel Carle Grandmougin
Chief Scientific Officer
€+22.2m
Denis Fortier
General Manager
€+23.6m
Denis Fortier
General Manager
€-10.5m
Denis Fortier
General Manager
€-494.8k
Denis Fortier
General Manager
€-168.5k
Jean-Michel Carle Grandmougin
Chief Scientific Officer
€-9.2k
View All Transactions

During the last 3 months Eurobio Scientific SA insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 0% over this period (open performance analysis).

The last transaction was made on Dec 18, 2023 by Denis Fortier (General Manager) , who bought 7.6k EUR worth of ALERS shares.

Sold
0-3
months
0 EUR
0
3-6
months
0 EUR
0
6-9
months
0 EUR
0
9-12
months
0 EUR
0
Bought
0-3
months
No Insider Transactions
0
0 EUR
3-6
months
No Insider Transactions
0
0 EUR
6-9
months
No Insider Transactions
0
0 EUR
9-12
months
No Insider Transactions
0
0 EUR

Eurobio Scientific SA
Insider Trading Chart

Eurobio Scientific SA
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Eurobio Scientific SA
Last Insider Transactions

Global
Insiders Monitor

Eurobio Scientific SA
Glance View

Market Cap
254.2m EUR
Industry
Biotechnology

Eurobio-Scientific SA engages in designing, development and commercialization of tests diagnosis in the fields of transplantation, infectious diseases, autoimmunity and oncology, as well as products for research in the field of life sciences. The company is headquartered in Les Ulis, Ile-De-France. The company went IPO on 2005-11-18. The company is engaged in activities ranging from discovery to the commercialization of specialty diagnostic products. The firm owns a portfolio of diagnostic products in three specialty areas: infectious diseases; Alzheimer's disease, and cancer. The company consists of Tetanos Quick Stick (TQS), which is an unitary test enabling to determine the tetanus vaccination status. The company has a portfolio of in-house and co-developed products, including AclarusDx (a blood-based test for the detection of biomarkers specific for Alzheimer's disease). The portfolio includes BJI Inoplex for prosthetic infections and EHT Dx14 for breast cancer (both in validation phase). The co-developed products include research programs for the identification of predictive biomarkers of response for anti-HER2 and anti-angiogenic therapies, among others. The company operates through Genbio and Eurobio Capforce Plus.

ALERS Intrinsic Value
17.36 EUR
Overvaluation 32%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top